Repare Therapeutics Inc. (RPTX) Tops Q3 EPS by 57c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q3 EPS of $0.08, $0.57 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $11.62 million versus the consensus estimate of $7.5 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
• ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
• Stripe, Advent In Talks To Buy Paypal - WSJ